FDA Makes Temporary Rules While Writing The Real Rules
Published Date: 1/7/2025
Notice
Summary
The FDA just released a new interim policy for pharmacies that mix medicines using bulk drug ingredients. This update affects compounders who aren’t big outsourcing facilities and sets clearer rules while the FDA finalizes an official list of allowed bulk drugs. The policy kicks in January 2025 and aims to keep medicine mixing safe without slowing down your prescriptions or adding extra costs.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Enforcement Safe Harbor for Compounders
If you are a State-licensed pharmacy, Federal facility, or licensed physician who compounds human drugs, FDA says it does not intend to take action against certain compounding using bulk drug substances while it develops the 503A bulks list. The guidance describing this interim policy was published on January 7, 2025.
End of Category 1–3 Nominations Categorization
For bulk drug substances nominated on or after January 7, 2025, FDA will no longer place those nominations into Categories 1, 2, or 3. Instead, FDA will consider such nominations for inclusion on the statutory 503A bulks list according to the FD&C Act and its regulations.
Transitional Protection for Prior Category 1 Substances
Bulk drug substances that were in Category 1, including those nominated with adequate supporting information before January 7, 2025, may remain within the scope of the Category 1 interim policy until FDA issues a final rule placing them on the 503A bulks list or removes them from Category 1. This allows existing Category 1 substances to continue under the prior interim policy while FDA completes rulemaking or reevaluation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11331 — Hand Trucks and Certain Parts Thereof From the People's Republic of China: Final Results of the Expedited Fourth Sunset Review of the Antidumping Duty Order
The U.S. Department of Commerce decided to keep the antidumping duties on hand trucks and parts from China because dropping them could lead to unfair low prices again. This means importers from China will still pay extra fees to keep things fair for U.S. businesses. These rules stay in effect starting June 5, 2026, protecting American companies from cheap imports that could hurt them.
2026-11280 — Self-Regulatory Organizations; NYSE American LLC; Order Instituting Proceedings To Determine Whether To Approve or Disapprove a Proposed Rule Change To Amend Sections 1003 and 1009 of the NYSE American Company Guide
The NYSE American Exchange wants to change its rules to require companies to keep a certain market value to stay listed. This affects companies listed on the exchange and could lead to some being removed if they don’t meet the new standards. The SEC is reviewing this change and will decide by June 18, 2026, so companies and investors should watch for updates that might impact stock listings and market activity.
2026-11296 — Notice of Determinations and Request for Comments Concerning Actions in Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure To Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor
The U.S. Trade Representative found that many countries aren’t stopping goods made with forced labor from entering the U.S. To fix this, they’re planning to add extra taxes (tariffs) on products from these countries, with rates between 10% and 12.5%. They’re also offering a special deal for some clothing imports and want your thoughts before finalizing these changes by early July 2026.
2026-11327 — Proposed Revisions to the National Handbook of Conservation Practices
The USDA’s Natural Resources Conservation Service is updating some rules in the National Handbook of Conservation Practices to help farmers and landowners protect the environment better. These changes could affect how conservation projects are planned and done, and the public can share their thoughts until July 6, 2026. No big costs are expected, but the updates aim to make conservation easier and more effective.
2026-11276 — Long Island Rail Road's Request To Amend Its Positive Train Control System
The Long Island Rail Road wants to make some changes to its safety system that helps prevent train crashes, called Positive Train Control (PTC). They asked the government for approval on May 21, 2026, and now the public can share their thoughts until June 25, 2026. These updates aim to keep trains safer without causing delays or extra costs for riders.
2026-11282 — Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Designation of a Longer Period for Commission Action on a Proposed Rule Change To Amend It Rules Related to Binary Options
The Cboe Exchange wants to update its rules to let traders buy and sell binary options on more indexes, with flexible settlement times and new position limits. The SEC is taking extra time, until July 19, 2026, to review these changes carefully. This affects traders and could impact how they manage risk and trade binary options on the Exchange.
Previous / Next Documents
Previous: 2024-31545 — Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
The FDA just released a new interim policy for pharmacies that mix medicines using bulk drug ingredients. This update affects outsourcing facilities by setting clearer rules while the FDA finishes a list of approved bulk drugs. Starting January 7, 2025, these changes help keep medicines safe without slowing down production or adding extra costs right now.
Next: 2024-31547 — Notifying the Food and Drug Administration of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA has released updated rules for medical device makers about telling the agency if they stop or pause making certain devices. This new guidance lists which devices need mandatory notifications and lets companies share supply problems anytime, even without a health emergency. These changes help keep important medical devices available and give manufacturers clear deadlines to avoid surprises.